Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
Jun J. Mao
Research Funding: Tibet Cheezheng Tibetan Medicine Co Ltd (Inst)
Nofisat Ismaila
Employment: GlaxoSmithKline (I)
Stock and Other Ownership Interests: GlaxoSmithKline (I)
Ting Bao
Research Funding: Merck
Eric L. Garland
Consulting or Advisory Role: BehaVR LLC
Patents, Royalties, Other Intellectual Property: I am a licensor to BehaVR LLC, I have licensed my Mindfulness-Oriented Recovery Enhancement intervention to BehaVR so the company could develop a virtual reality version of the therapy. I receive royalties for this license.
Other Relationship: Myself
Thomas Leblanc
Honoraria: AbbVie, Astellas Pharma, Agilix
Consulting or Advisory Role: Pfizer, AbbVie/Genentech, AstraZeneca, Flatiron Health, Bristol Myers Squibb/Celgene, GlaxoSmithKline, Astellas Pharma, Blue Note Therapeutics
Speakers' Bureau: Agios, AbbVie, Bristol Myers Squibb/Celgene
Research Funding: AstraZeneca (Inst), Jazz Pharmaceuticals (Inst), Bristol Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property: UpToDate Inc, royalty
Travel, Accommodations, Expenses: Agios, AbbVie/Genentech, Bristol Myers Squibb/Celgene
Richard T. Lee
Research Funding: Merck (Inst), Incyte (Inst), Yivia (Inst)
Uncompensated Relationships: Grow Ohio Pharmaceuticals
Ana Maria Lopez
Research Funding: Bristol Myers Squibb
Charles Loprinzi
Consulting or Advisory Role: PledPharma, Metys Pharmaceuticals, Disarm Therapeutics, OnQuality Pharmaceuticals, NKMax, Mitsubishi Tanabe Pharma, Veloxis, Hengrui Pharmaceutical, Osmol Therapeutics, Grunenthal, Neuropathix, Denali Therapeutics
Research Funding: Bristol Myers Squibb (Inst)
Other Relationship: Cynosure/Hologic
Gary H. Lyman
Honoraria: Sandoz, Partners Healthcare, Squibb, Seattle Genetics, Teva, Jazz Pharmaceuticals
Consulting or Advisory Role: G1 Therapeutics, Samsung Bioepis, BeyondSpring Pharmaceuticals, MSD, Fresenius Kabi
Research Funding: Amgen (Inst)
Viraj A. Master
Honoraria: Ethicon
Kavitha Ramchandran
Consulting or Advisory Role: Drishti, Group Well, Varian Medical Systems
Lynne I. Wagner
Stock and Other Ownership Interests: Johnson & Johnson (I), Lilly (I), Gilead Sciences (I)
Consulting or Advisory Role: Celgene, Athenex
Travel, Accommodations, Expenses: Celgene
Deborah Watkins Bruner
Employment: Emory University
Stock and Other Ownership Interests: AbbVie, Altria, Bristol Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Pfizer, Procter & Gamble, Stryker, Viatris, Walgreens Boots Alliance
Honoraria: American Society of Radiation Oncology (ASTRO), Oncology Nursing Society, Memorial Sloan-Kettering Cancer Center, Alliance, Wilmont Cancer Center
Consulting or Advisory Role: Flatiron Health, Alliance for Clinical Trials in Oncology, University of Rochester
Claudia M. Witt
Research Funding: CERES (Inst), Newsenselab (Inst)
Eduardo Bruera
Research Funding: PharmaCann Inc (Inst)
No other potential conflicts of interest were reported.
留言 (0)